Australian nootropic company Neuratech is switching from capsules to powders after regulators introduced new rules meaning pill-based products would be classed at therapeutic goods.
New Zealand nootropic company Ārepa is investing over NZ$2 million (US$1.4m) on a series of brain health and performance clinical trials as it looks to create the world’s smartest drink.
Indian firm Enovate Bio says the current COVID-19 pandemic has presented growth opportunities for its plant-based nootropic ingredient – EnXtra – in the area of e-gaming.
New Zealand’s Ārepa is aiming to be present in all supermarkets nationwide by the end of this year and looking to expand in the Australia and US markets, on the back of the ‘credibility boost’ of winning a NutraIngredients-Asia Award.
As industrialized nations continue to move away from manual labor toward tech- and creative-based economies, it is about time that nootropic products become more mainstream, says the CEO and founder of Koios.
There has been an increased demand for testing nootropic dietary supplements, according to several analytical labs. How can companies substantiate claims around cognitive benefits?
